Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes
NHS hospitals in England used £82,490,746 of indicative cost of Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 6.6mg/165microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Western Sussex Hospitals Nhs Found Trust | £4,670,050 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,928,306 |
| Moorfields Eye Hospital Nhs Ft | £3,414,226 |
| Univ Hpls Bristol Nhs Foundation Trust | £3,394,397 |
| University Hospitals Dorset Nhs Ft | £2,881,786 |
| Ashford & St Peter's Hospitals Nhs Ft | £2,558,650 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,481,538 |
| York Teaching Hospital Nhs Ft | £2,389,003 |
| Oxford University Hospitals Nhs Ft | £2,332,454 |
| East Kent Hospitals University Nhs Ft | £2,220,091 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.